Harel Insurance Investments & Financial Services Ltd. Moleculin Biotech, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.16 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021
SELL
$3.21 - $4.06 $32,100 - $40,599
-10,000 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$3.7 - $6.42 $37,000 - $64,200
10,000 New
10,000 $136,000

Others Institutions Holding MBRX

# of Institutions
2
Shares Held
3.35K
Call Options Held
0
Put Options Held
0
View Full List

About Moleculin Biotech, Inc.

MBRX Quotes by TradingView
  • Ticker MBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,606,700
  • Market Cap $124M
  • Description
  • Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....
More about MBRX
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email